"nivolumab" meaning in All languages combined

See nivolumab on Wiktionary

Noun [English]

IPA: /nɪˈvɒljʊˌmæb/
Etymology: -l- (“immunomodulating”) + -umab (“human monoclonal antibody”) Etymology templates: {{af|en|-l-|-umab|t1=immunomodulating|t2=human monoclonal antibody}} -l- (“immunomodulating”) + -umab (“human monoclonal antibody”) Head templates: {{en-noun|-}} nivolumab (uncountable)
  1. (pharmacology) a human IgG4 anti-PD-1 monoclonal antibody, acting as a checkpoint inhibitor, thus allowing activated T cells to attack cancer cells Wikipedia link: nivolumab Tags: uncountable Categories (topical): Pharmaceutical drugs

Download JSON data for nivolumab meaning in All languages combined (1.8kB)

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "-l-",
        "3": "-umab",
        "t1": "immunomodulating",
        "t2": "human monoclonal antibody"
      },
      "expansion": "-l- (“immunomodulating”) + -umab (“human monoclonal antibody”)",
      "name": "af"
    }
  ],
  "etymology_text": "-l- (“immunomodulating”) + -umab (“human monoclonal antibody”)",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "nivolumab (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms interfixed with -l-",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms suffixed with -umab",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "topical",
          "langcode": "en",
          "name": "Pharmaceutical drugs",
          "orig": "en:Pharmaceutical drugs",
          "parents": [
            "Drugs",
            "Matter",
            "Pharmacology",
            "Chemistry",
            "Nature",
            "Biochemistry",
            "Medicine",
            "Sciences",
            "All topics",
            "Biology",
            "Fundamental"
          ],
          "source": "w"
        }
      ],
      "glosses": [
        "a human IgG4 anti-PD-1 monoclonal antibody, acting as a checkpoint inhibitor, thus allowing activated T cells to attack cancer cells"
      ],
      "id": "en-nivolumab-en-noun-x0dgfTYe",
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "IgG4",
          "IgG4"
        ],
        [
          "PD-1",
          "PD-1"
        ],
        [
          "monoclonal antibody",
          "monoclonal antibody"
        ],
        [
          "checkpoint inhibitor",
          "checkpoint inhibitor"
        ],
        [
          "T cells",
          "T cells"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) a human IgG4 anti-PD-1 monoclonal antibody, acting as a checkpoint inhibitor, thus allowing activated T cells to attack cancer cells"
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ],
      "wikipedia": [
        "nivolumab"
      ]
    }
  ],
  "sounds": [
    {
      "ipa": "/nɪˈvɒljʊˌmæb/"
    }
  ],
  "word": "nivolumab"
}
{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "-l-",
        "3": "-umab",
        "t1": "immunomodulating",
        "t2": "human monoclonal antibody"
      },
      "expansion": "-l- (“immunomodulating”) + -umab (“human monoclonal antibody”)",
      "name": "af"
    }
  ],
  "etymology_text": "-l- (“immunomodulating”) + -umab (“human monoclonal antibody”)",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "nivolumab (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        "English 4-syllable words",
        "English entries with incorrect language header",
        "English lemmas",
        "English nouns",
        "English terms interfixed with -l-",
        "English terms suffixed with -umab",
        "English terms with IPA pronunciation",
        "English uncountable nouns",
        "en:Pharmaceutical drugs"
      ],
      "glosses": [
        "a human IgG4 anti-PD-1 monoclonal antibody, acting as a checkpoint inhibitor, thus allowing activated T cells to attack cancer cells"
      ],
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "IgG4",
          "IgG4"
        ],
        [
          "PD-1",
          "PD-1"
        ],
        [
          "monoclonal antibody",
          "monoclonal antibody"
        ],
        [
          "checkpoint inhibitor",
          "checkpoint inhibitor"
        ],
        [
          "T cells",
          "T cells"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) a human IgG4 anti-PD-1 monoclonal antibody, acting as a checkpoint inhibitor, thus allowing activated T cells to attack cancer cells"
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ],
      "wikipedia": [
        "nivolumab"
      ]
    }
  ],
  "sounds": [
    {
      "ipa": "/nɪˈvɒljʊˌmæb/"
    }
  ],
  "word": "nivolumab"
}

This page is a part of the kaikki.org machine-readable All languages combined dictionary. This dictionary is based on structured data extracted on 2024-06-19 from the enwiktionary dump dated 2024-06-06 using wiktextract (372f256 and 664a3bc). The data shown on this site has been post-processed and various details (e.g., extra categories) removed, some information disambiguated, and additional data merged from other sources. See the raw data download page for the unprocessed wiktextract data.

If you use this data in academic research, please cite Tatu Ylonen: Wiktextract: Wiktionary as Machine-Readable Structured Data, Proceedings of the 13th Conference on Language Resources and Evaluation (LREC), pp. 1317-1325, Marseille, 20-25 June 2022. Linking to the relevant page(s) under https://kaikki.org would also be greatly appreciated.